Last C$1.40 CAD
Change Today +0.10 / 7.69%
Volume 2.6K
BLU On Other Exchanges
Symbol
Exchange
Toronto
OTC US
Frankfurt
As of 1:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald M. Nordmann

Former Lead Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, BELLUS Health Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

72--

Background*

Mr. Ronald M. Nordmann has been Co-President of Global Health Associates LLC since October 2000. Mr. Nordmann has been a Financial Analyst in Healthcare Equities since 1971. From September 1994 to December 1999, he served as a Partner and Portfolio Manager of Deerfield Management. From December 1999 to October 2000, Mr. Nordmann was a private investor. From September 1994 to January 2000, he served as a Financial Analyst of Deerfield Management and a limited partner ...

Read Full Background

Corporate Headquarters*

275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7

Canada

Phone: 450-680-4500
Fax: 450-680-4501

Board Members Memberships*

Director Nominee
Director
Former Member of the Board of Directors
Director
1999-2006
Former Non-Executive Director, Member of Audit Committee, Member of Nomination Committee and Member of Remuneration Committee
2000-N/A
Former Director
2000-N/A
Former Director, Chairman of Nominating and Governance Committee and Member of Audit Committee
2001-2012
Former Director, Chairman of Nominating-Corporate Governance Committee and Member of Audit Committee
2002-2006
Former Lead Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

MBA 1966
Fairleigh Dickinson University
BA 1963
Johns Hopkins University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLU:CN C$1.40 CAD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Robert H. Gundel Ph.D., M.B.A.Chief Executive Officer, President, Non Independent Director and Member of Financing Committee
Amorfix Life Sciences Ltd.
C$283.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BELLUS HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.